Stay updated on Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a Locations section listing Florida. Updated the page revision to v3.3.3; the Florida Locations label and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-22T22:38:14.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:27:47.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Minor edits to the Publications section note clarifying that publications are provided voluntarily by the person entering information about the study and pertain to the results. A new Revision: v3.3.1 was added; the previous version was v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T12:17:14.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Notice about government funding and NIH Clinical Center operating status was removed from the page. All study details and trial information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:22:22.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Added a Study Results section and a Publications entry (Biomarker Research 2022) for pembrolizumab activity in Fanconi anemia pathway tumors on the Study Details page.
    Difference
    0.5%
    Check dated 2025-11-03T00:59:42.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    4%
    Check dated 2025-10-05T09:18:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.